Pharma's Dirty Secret, And The Synthetic Biology Startup Offering A New Approach

Octant Bio recently raised a $30M Series A to do something about this. The Bay Area, CA-based synthetic biology startup is using an approach you may …

To Read More, Please Visit Source

Related Articles

Back to top button